TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/26 18:22 | 3/9/26 | INKT | Mink Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ryan Barbara | NY | D | S.m | -22 | 14.70 | 0 | -2 | -7 | 20 | D | |||||||||||||||
3/11/26 08:12 | 3/9/26 | INDV | Indivior Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Ryan Barbara | VA | D | P | 1 | 32.56 | 0 | 0 | 1 | 6 | D | |||||||||||||||
3/4/26 16:45 | 2/27/26 | INKT | Mink Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ryan Barbara | NY | D | S.m | -5 | 10.85 | 0 | -1 | -2 | 22 | D | |||||||||||||||
1/7/26 13:51 | 1/5/26 | INDV | Indivior Plc | X0 | Health | Drug | Pharmaceutical Preparations | Ryan Barbara | VA | D | P | 27 | 35.39 | 0 | 1 | 65 | 2 | D | |||||||||||||||
6/3/22 18:45 | 6/1/22 | INVO | Invo Bioscience, Inc. | NV | Health | MdEq | Surgical & Medical Instrument | Ryan Barbara | FL | D | P | 10 | 0.9500 | 0 | 11 | 84 | 23 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |